Stevens Capital Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Stevens Capital Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-25,333	Closed	-$1.16M	–	1111
2017 Q4	$1.16M	Buy	+25,333	New	+$1.26M	0.04%	404
2016 Q1	–	Sell	-52,641	Closed	-$2.31M	–	1229
2015 Q4	$2.31M	Buy	+52,641	New	+$2.61M	0.09%	265
2015 Q3	–	Sell	-5,773	Closed	-$308K	–	1358
2015 Q2	$308K	Buy	+5,773	New	+$306K	0.01%	746

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Stevens Capital Management's JUNO Position: Q1 2018 in Review

Stevens Capital Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 25,333 shares — an estimated $1.16M sold.

Stevens Capital Management first reported a position in JUNO in Q2 2015 and held it in 3 quarters. The position peaked at $2.31M in Q4 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Stevens Capital Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Stevens Capital Management sold 25,333 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.16M.
Stevens Capital Management first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 3 quarters.
Stevens Capital Management's Juno Therapeutics, Inc. position peaked at $2.31M in Q4 2015.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Stevens Capital Management's 13F filing for Q1 2018, filed 8 May 2018.